Méthanoanthracènes comme antagonistes de dopamine

Methanoanthracenes as dopamine antagonists

Methanoanthracene als Dopaminantagonisten

Abstract

Compounds of formula I, la or Ib and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychiatric disorders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable diluent or carrier; and methods of treating neuropschiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (7)

    Publication numberPublication dateAssigneeTitle
    DE-2556143-A1June 16, 1976Sumitomo Chemical Co9-aminoalkyl-9,10-dihydro-9,10- methanoanthracene
    JP-S52122358-AOctober 14, 1977Sumitomo Chem Co LtdNovel methano-anthracene derivatives
    JP-S527953-AJanuary 21, 1977Sumitomo Chem Co LtdPreparation of novel methano-anthracene derivatives
    US-4153629-AMay 08, 1979Shionogi & Co., Ltd.9,10-Dihydro-9,10-methanoanthracene N-oxide
    US-4216231-AAugust 05, 1980Shionogi & Co., Ltd.9,10-Dihydro-9,10-methanoanthracene N-oxide derivatives
    US-4224344-ASeptember 23, 1980Sumitomo Chemical Company, LimitedOrganic tricyclic compounds
    US-4358620-ANovember 09, 1982Sumitomo Chemical Company, Limited9-Formyl-9,10-dihydro-9,10-methanoanthracene

NO-Patent Citations (3)

    Title
    CHEM. PHARM. BULL. vol. 27, no. 8, 1979, pages 1806 - 1812; M. SUNAGAWA ET AL.: 'Dibenzotetracyclic Derivatives. II. Synthesis of 9-Aminoalkyl-9,10 dihydro-9,10-methanoanthracenes'
    PATENT ABSTRACTS OF JAPAN vol. 1, no. 48 (C-012)11 May 1977 & JP-A-52 007 953 ( SUMITOMO CHEMICAL CO., LTD. ) 21 January 1977
    PATENT ABSTRACTS OF JAPAN vol. 2, no. 24 (C-003)16 February 1978 & JP-A-52 122 358 ( SUMITOMO CHEMICAL CO., LTD. ) 14 October 1977

Cited By (16)

    Publication numberPublication dateAssigneeTitle
    EP-0624590-A1November 17, 1994Ciba-Geigy AgN-acylated staurosporine derivatives, process and intermediates for their preparation and their use as medicaments
    US-5382675-AJanuary 17, 1995Ciba-Geigy CorporationPolycyclic compounds and processes for the preparation thereof
    US-5455241-AOctober 03, 1995Ciba-Geigy CorporationPolycyclic compounds and processes for the preparation thereof
    US-5514683-AMay 07, 1996James Black Foundation LimitedBicyclo 2,2,2!octane derivatives
    US-6159982-ADecember 12, 2000Janssen Pharmaceutica N. V.2,4-diaminopyrimidine derivates as dopamine D4 receptor antagonist
    US-6395742-B1May 28, 2002Janssen Pharmaceutica N.V.2,4-diaminopyrimidine derivatives
    US-8530474-B2September 10, 2013Janssen Pharmaceutica NvSubstituted 6-(1-piperazinyl)-pyridazines as 5-HT6 receptor antagonists
    US-8895562-B2November 25, 2014Janssen Pharmaceutica NvPiperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
    US-8906921-B2December 09, 2014Janssen Pharmaceutica Nv4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
    US-8933101-B2January 13, 2015Janssen Pharmaceutica NvThia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
    US-8940743-B2January 27, 2015Janssen Pharmaceutica NvPiperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
    US-9422296-B2August 23, 2016Janssen Pharmaceutica NvFast-dissociating dopamine 2 receptor antagonists
    US-9468640-B2October 18, 2016Janssen Pharmaceutica NvPiperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
    US-9751860-B2September 05, 2017Janssen Pharmaceutica NvPiperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
    WO-2012139993-A1October 18, 2012F. Hoffmann-La Roche Ag, Siena Biotech S.P.A1,3 oxazines as bace1 and/or bace2 inhibitors
    WO-9743279-A1November 20, 1997Janssen Pharmaceutica N.V.Derives de la 2,4-diaminopyrimidine utilises comme antagonistes du recepteur d4 de la dopamine